Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Quantifying the relative amount of mouse and human DNA in cancer xenografts using species-specific variation in gene length.

Lin MT, Tseng LH, Kamiyama H, Kamiyama M, Lim P, Hidalgo M, Wheelan S, Eshleman J.

Biotechniques. 2010 Mar;48(3):211-8. doi: 10.2144/000113363.

2.

Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts.

Alcoser SY, Kimmel DJ, Borgel SD, Carter JP, Dougherty KM, Hollingshead MG.

BMC Biotechnol. 2011 Dec 16;11:124. doi: 10.1186/1472-6750-11-124.

3.

Beware of contaminating mouse cells in human xenografts from nude mice.

Yang J, Liu A, Dougherty C, Chen X, Guzman R, Nandi S.

Anticancer Res. 2000 May-Jun;20(3A):1635-9.

PMID:
10928083
4.

Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.

Loukopoulos P, Kanetaka K, Takamura M, Shibata T, Sakamoto M, Hirohashi S.

Pancreas. 2004 Oct;29(3):193-203.

PMID:
15367885
5.

Mouse fibroblast activation protein: molecular cloning, alternative splicing and expression in the reactive stroma of epithelial cancers.

Niedermeyer J, Scanlan MJ, Garin-Chesa P, Daiber C, Fiebig HH, Old LJ, Rettig WJ, Schnapp A.

Int J Cancer. 1997 May 2;71(3):383-9.

6.

Genetic mapping of 40 cDNA clones on the mouse genome by PCR.

Ko MS, Wang X, Horton JH, Hagen MD, Takahashi N, Maezaki Y, Nadeau JH.

Mamm Genome. 1994 Jun;5(6):349-55.

PMID:
8043949
7.

Growth of human digestive-tumour xenografts in athymic nude rats.

Davies G, Duke D, Grant AG, Kelly SA, Hermon-Taylor J.

Br J Cancer. 1981 Jan;43(1):53-8.

8.
9.

Stability of ras oncogene mutation in the human tumor xenografts through serial passages.

Kijima H, Abe Y, Yamazaki H, Ohnishi Y, Ueyama Y, Tamaoki N, Nakamura M.

Anticancer Res. 1994 Nov-Dec;14(6B):2583-7.

PMID:
7872685
10.

Xenografting and harvesting human ductal pancreatic adenocarcinomas for DNA analysis.

Walter K, Eshleman J, Goggins M.

Methods Mol Med. 2005;103:103-11.

PMID:
15542900
11.

Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.

Nemeth JA, Harb JF, Barroso U Jr, He Z, Grignon DJ, Cher ML.

Cancer Res. 1999 Apr 15;59(8):1987-93.

12.

RIKEN integrated sequence analysis (RISA) system--384-format sequencing pipeline with 384 multicapillary sequencer.

Shibata K, Itoh M, Aizawa K, Nagaoka S, Sasaki N, Carninci P, Konno H, Akiyama J, Nishi K, Kitsunai T, Tashiro H, Itoh M, Sumi N, Ishii Y, Nakamura S, Hazama M, Nishine T, Harada A, Yamamoto R, Matsumoto H, Sakaguchi S, Ikegami T, Kashiwagi K, Fujiwake S, Inoue K, Togawa Y.

Genome Res. 2000 Nov;10(11):1757-71.

13.
14.
15.

Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts.

Bockhorn M, Tsuzuki Y, Xu L, Frilling A, Broelsch CE, Fukumura D.

Clin Cancer Res. 2003 Sep 15;9(11):4221-6.

16.

Characterizing DNA methylation patterns in pancreatic cancer genome.

Tan AC, Jimeno A, Lin SH, Wheelhouse J, Chan F, Solomon A, Rajeshkumar NV, Rubio-Viqueira B, Hidalgo M.

Mol Oncol. 2009 Dec;3(5-6):425-38. doi: 10.1016/j.molonc.2009.03.004. Epub 2009 Apr 22.

17.

Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models.

Bergamaschi A, Hjortland GO, Triulzi T, Sørlie T, Johnsen H, Ree AH, Russnes HG, Tronnes S, Maelandsmo GM, Fodstad O, Borresen-Dale AL, Engebraaten O.

Mol Oncol. 2009 Dec;3(5-6):469-82. doi: 10.1016/j.molonc.2009.07.003. Epub 2009 Aug 4.

19.

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1.

Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE.

Science. 1996 Jan 19;271(5247):350-3.

PMID:
8553070

Supplemental Content

Support Center